Mutation analysis of CTNNB1 (β-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1195-1200

  Su, Tsung Hsien ^a,b   Chang, Jan Gowth ^a   Yeh, Kun Tu ^c   Lin, Ting Hsu ^a   Lee, Tai Ping ^a   Chen, Jui Chang ^a   Lin, Cheng Chieh ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

AXIN1; Cervical cancer; CTNNB1; Mutation analysis; Wnt pathway

Indexed keywords

AXIN PROTEIN; DNA; ONCOPROTEIN; PRIMER DNA; REPRESSOR PROTEIN; WNT PROTEIN; ZEBRAFISH PROTEIN;

ADULT; AGED; ARTICLE; CHEMISTRY; CODON; DNA SEQUENCE; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; SINGLE STRAND CONFORMATION POLYMORPHISM; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CODON; DNA; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 2142858730     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1195     Document Type: Article

References (30)

1. Boring CC, Squires TS and Tong T: Cancer statistics, 1993. CA Cancer J Clin 43: 7-26, 1993. (Pubitemid 23049040)
2. Howley PM: Role of human papilloma viruses in human cancer. Cancer Res 51: 5019-5022, 1991.
3. Murthy NS, Sehgal A, Satyanarayana L, Das DK, Singh V, Das BC, Gupta MM, Mitra AB and Luthra UK: Risk factors related to biological behavior of precancerous lesions of the uterine cervix. Br J Cancer 61: 732-736, 1990. (Pubitemid 20151341)
4. Zur Hausen H: Viruses in human cancers. Science 254: 1167-1173, 1991.
5. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790, 1997. (Pubitemid 27136715)
6. Peifer M: β-catenin as oncogene: the smoking gun. Science 275: 1752-1753, 1997.
7. Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, Ishiguro S, Nakamura Y and Miyoshi Y: Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58: 1021-1026, 1998. (Pubitemid 28182473)
8. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H: Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science 275: 1784-1787, 1997. (Pubitemid 27136714)
9. Sparks AB, Morin PJ, Vogelstein B and Kinzler KW: Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130-1134, 1998. (Pubitemid 28183198)
10. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E and Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792, 1997. (Pubitemid 27136716)
11. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y and Nakamura Y: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250, 2000. (Pubitemid 30132191)
12. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790, 1997. (Pubitemid 27136715)
13. Ahmed Y, Hayashi S, Levine A and Wieschaus E: Regulation of armadillo by a Drosophila APC inhibits neuronal apoptosis during retinal development. Cell 93: 1171-1182, 1998. (Pubitemid 28307422)
14. Farr GH III, Ferkey DM, Yost C, Pierce SB, Weaver C and Kimelman D: Interaction among GSK-3, GBP, axin and APC in Xenopus axis specification. J Cell Biol 148: 691-702, 2000.
15. He X, Saint-Jeannet JP, Woodgett JR, Varmus HE and Dawid IB: Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature 347: 617-622, 1995.
16. Hedgepeth CM, Deardorff MA and Klein PS: Xenopus axin interacts with glycogen synthase kinase-3 beta and is expressed in the anterior midbrain. Mech Dev 80: 147-151, 1999. (Pubitemid 29125425)
17. Barker N, Morin PJ and Clevers H: The Yin-Yang of TCF/β-catenin signaling. Adv Cancer Res 77: 1-24, 2000.
18. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S and Kikuchi A: Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 17: 1731-1784, 1998.
19. Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S and Kikuchi A: Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3β regulates its stability. J Biol Chem 274: 10681-10684, 1999.
20. Li L, Yuan H, Weaver CD, Mao J, Farr GH III, Sussman DJ, Jonkers J, Kimelman D and Wu D: Axin and Fratl interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J 18: 4233-4240, 1999. (Pubitemid 29364125)
21. Willert K, Shibamoto S and Nusse R: Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex. Genes Dev 13: 1768-1773, 1999. (Pubitemid 29353044)
22. Moon RT, Bowerman B, Boutros M and Perrimon N: The promise and perils of Wnt signaling through β-catenin. Science 296: 1644-1646, 2002. (Pubitemid 34579151)
23. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
24. Koch A, Waha A, Tonn JC, Sorensen N, Berthold F, Wolter M, Reifenberger J, Hartmann W, Friedl W, Reifenberger G, Wiestier OD and Pietsch T: Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 93: 445-449, 2001. (Pubitemid 32592067)
25. Shinohara A, Yokoyama Y, Wan X, Takahashi Y, Mori Y, Takami T, Shimokawa K and Tamaya T: Cytoplasmic/nuclear expression without mutation of exon 3 of the β-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Gynecol Oncol 82: 450-455, 2001. (Pubitemid 32826443)
26. Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M and Drabkin HA: Mutations of the beta-and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 85: 64-68, 2001. (Pubitemid 32695717)
27. Su TH, Wang JC, Tseng HH, Chang CP, Chang TA, Wei HJ and Chang JG: Analysis of FHIT transcripts in cervical and endometrial cancers. Int J Cancer 76: 216-222, 1998.
28. Su TH, Chang JG, Perng LI, Chang CP, Wei HJ, Wang NM and Tsai CH: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer. Gynecol Oncol 76: 193-199, 2000. (Pubitemid 30067194)
29. Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F, Behrens J, Birchmeier W, Wiestier OD and Pietsch T: Deletions of AXIN1, a component of the WNT/ wingless pathway, in sporadic medulloblastomas. Cancer Res 61: 7039-7043, 2001. (Pubitemid 32946492)
30. Pereira-Suarez AL, Meraz MA, Lizano M, Estrada-Chavez C, Hernandez F, Olivera P, Perez E, Padilla P, Yaniv M, Thierry F and Garcia-Carranca A: Frequent alterations of the beta-catenin protein in cancer of the uterine cervix. Tumour Biol 23: 45-53, 2002. (Pubitemid 34225021)